State Street Corp Belite Bio, Inc Transaction History
State Street Corp
- $2.41 Trillion
- Q3 2024
A detailed history of State Street Corp transactions in Belite Bio, Inc stock. As of the latest transaction made, State Street Corp holds 20,086 shares of BLTE stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,086
Previous 15,671
28.17%
Holding current value
$1.25 Million
Previous $715,000
31.61%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BLTE
# of Institutions
16Shares Held
78.7KCall Options Held
0Put Options Held
0-
Bank Of America Corp Charlotte, NC13.5KShares$839,8800.0% of portfolio
-
Marshall Wace, LLP London, X08.49KShares$529,8650.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.7KShares$418,3480.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il6.46KShares$403,3620.0% of portfolio
-
Jpmorgan Chase & CO New York, NY6.36KShares$396,8680.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.55B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...